Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Sep 3;204(9):2015-21.
doi: 10.1084/jem.20070841. Epub 2007 Aug 13.

Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells

Andrew M Intlekofer  1 , Naofumi Takemoto, Charlly Kao, Arnob Banerjee, Felix Schambach, John K Northrop, Hao Shen, E John Wherry, Steven L Reiner
Affiliations

Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells

Andrew M Intlekofer et al. J Exp Med. .

Abstract

Immunity to intracellular pathogens requires dynamic balance between terminal differentiation of short-lived, cytotoxic effector CD8+ T cells and self-renewal of central-memory CD8+ T cells. We now show that T-bet represses transcription of IL-7Ralpha and drives differentiation of effector and effector-memory CD8+ T cells at the expense of central-memory cells. We also found T-bet to be overexpressed in CD8+ T cells that differentiated in the absence of CD4+ T cell help, a condition that is associated with defective central-memory formation. Finally, deletion of T-bet corrected the abnormal phenotypic and functional properties of "unhelped" memory CD8+ T cells. T-bet, thus, appears to function as a molecular switch between central- and effector-memory cell differentiation. Antagonism of T-bet may, therefore, represent a novel strategy to offset dysfunctional programming of memory CD8+ T cells.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
T-bet–mediated repression of IL-7Rα in effector CD8+ T cells. (A) IL-7Rα expression on CD8+ T cells from blood of wild-type or Tbx21 −/− mice 8 d after LCMV infection. Top row shows CD8+ T cells; middle and bottom rows show H-2DbGP33+ or H-2DbNP396+ T cells, respectively; the percentage of events are indicated. (B) Quantitative RT-PCR (Q-PCR) of IL-7Rα mRNA from P14 CD8+ (left) or DO11.10 CD4+ (right) T cells stimulated with peptide plus APCs and transduced with retrovirus. Cells sorted 5 d after transduction based on GFP. (C) IL-7Rα expression on DO11.10 CD4+ T cells in TH2 conditions stimulated and transduced as in B. Cells stained 5 d after transduction. (D) Q-PCR of P14 CD8+ T cells from spleens 8 d after infection sorted for IL-7Rαhi or IL-7Rαlo expression. Naive (CD44lo) CD8+ T cells are included in some graphs for reference. (E and F) Q-PCR of T-bet, Eomes, or Blimp-1 mRNA in LCMV-specific CD8+ T cells. H-2DbGP33+ plus H-2DbNP396+ CD8+ T cells sorted from spleens of wild-type mice at the indicated day after infection. Unfractionated tetramer-positive cells (E) or tetramer-positive cells fractionated by CD62Lhi or CD62Llo expression (F). Values for Q-PCR represent the mean ± the SEM of triplicate determinations, normalized to HPRT. All results are representative of at least three experiments.
Figure 2.
Figure 2.
Enhanced generation of central–memory CD8+ T cells in T-bet–deficient mice. (A–C) Phenotype of GP33-specific CD8+ T cells from spleens of wild-type or Tbx21 −/− mice 8 (A), 30 (B), or 140 d (C) after LCMV infection. Plots display H-2DbGP33+ events; the percentage of events are indicated. For bottom row, splenocytes were stimulated with GP33-41 peptide; numbers indicate the percentage producing both IFN-γ and IL-2. Results are representative of three experiments with multiple mice per time point. (D and E) Q-PCR of H-2DbGP33+ plus H-2bNP396+ CD8+ T cells from spleens of wild-type or Tbx21 −/− mice. (D) CCR7 and Blimp-1 mRNA 60 d after infection. Naive represents CD44loCD8+ T cells from uninfected wild-type mice. (E) Eomes mRNA 60 and 100 d after infection. Day 0 represents CD44loCD8+ T cells from uninfected wild-type or Tbx21 −/− mice. Results are representative of three similar experiments. (F) Quantification of LCMV-specific CD8+ T cells from wild-type or Tbx21 −/− mice 8, 30, and 60 d after infection. Left graph shows H-2DbGP33+ cells as the percentage of CD8+ in blood. Middle and right graphs show numbers of CD8+ T cells from spleen or lymph node (pooled axillary, inguinal, cervical, paraaortic, and mesenteric), respectively, producing IFN-γ in response to GP33-41. Results represent the mean ± the SEM for at least three mice per data point.
Figure 3.
Figure 3.
Enhanced secondary expansion and protection of T-bet–deficient memory cells. Equal numbers (2 × 105) of wild-type or Tbx21 −/− GP33-specific CD8+ T cells (Thy1.2+) isolated 45 d after LCMV infection and transferred to naive wild-type recipients (Thy1.1+). 1 d after transfer, recipient mice were infected with 2.5 × 105 CFU of L. monocytogenes. 4 d after challenge, spleens and livers were harvested to assess CD8+ T cell expansion and perform quantitative bacterial cultures. (A) Wild-type or Tbx21 −/− GP33-specific CD8+ T cell expansion. Graphs display numbers of transferred cells (Thy1.2+) from spleens of recipient mice producing IFN-γ or IL-2 in response to GP33-41. (B) Cytokine production by wild-type or Tbx21 −/− GP33-specific CD8+ T cells from spleens of recipient mice. Plots display CD8+ events; numbers indicate the percentage of cells producing both IFN-γ and IL-2 in response to GP33-41. (C) Bacterial load in mice that received wild-type or Tbx21 −/− GP33-specific CD8+ T cells. Spleens and livers were homogenized in 1% Triton X-100. Bacteria quantified by limiting dilution culture. Data for A and C represent the mean ± the SEM of six recipients of wild-type and four recipients of Tbx21 −/− cells. Results are representative of three similar experiments.
Figure 4.
Figure 4.
Enhanced T-bet expression in unhelped memory CD8+ T cells. (A) Phenotype of P14 cells from wild-type or Cd4 −/− hosts 60 d after infection. For bottom row, splenocytes were stimulated with GP33-41. Plots show CD8+ events; numbers indicate the percentage of P14 cells (Thy1.1+) expressing indicated surface marker or cytokine. (B and C) Intranuclear T-bet staining of P14 cells from wild-type or Cd4 −/− hosts 75 d after infection. (B) Plots show CD8+ events; numbers indicate MFI of T-bet staining in bulk P14 population (Thy1.1+). (C) Plots show P14 cells (Thy1.1+) from Cd4 −/− hosts; numbers represent MFI of T-bet staining in subsets with high or low expression of indicated marker. (D) Q-PCR of T-bet and Eomes mRNA in P14 cells from wild-type or Cd4 −/− hosts 60 d after infection. (E) Q-PCR of CCR7 and Blimp1 mRNA in P14 cells from wild-type or Cd4 −/− hosts 31, 46, or 60 d after infection. Values for Q-PCR represent the mean ± the SEM of triplicate determinations, normalized to HPRT. All results are representative of at least three experiments.
Figure 5.
Figure 5.
T-bet–dependent dysfunction of unhelped memory CD8+ T cells. (A and B) Wild-type or Tbx21 −/− mice were left untreated (No Tx) or treated with CD4-depleting antibody (0.2 mg GK1.5 i.p.; CD4 depleted) 1 d before and 1 d after LCMV infection. (A) Surface phenotype of GP33-specific CD8+ T cells from spleens 90 d after infection. Plots show H-2DbGP33+ events; numbers represent the percentage of tetramer-positive cells expressing indicated surface marker. (B) Cytokine production of GP33-specific CD8+ T cells. Plots show CD8+ events; numbers indicate the percentage of cells producing both IFN-γ and IL-2 or CD40L in response to GP33-41. Results are representative of two independent experiments.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Williams, M.A., and M.J. Bevan. 2007. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25:171–192. - PubMed
    1. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 401:708–712. - PubMed
    1. Wherry, E.J., V. Teichgraber, T.C. Becker, D. Masopust, S.M. Kaech, R. Antia, U.H. von Andrian, and R. Ahmed. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4:225–234. - PubMed
    1. Manjunath, N., P. Shankar, J. Wan, W. Weninger, M.A. Crowley, K. Hieshima, T.A. Springer, X. Fan, H. Shen, J. Lieberman, and U.H. von Andrian. 2001. Effector differentiation is not prerequisite for generation of memory cytotoxic T lymphocytes. J. Clin. Invest. 108:871–878. - PMC - PubMed
    1. Marzo, A.L., K.D. Klonowski, A. Le Bon, P. Borrow, D.F. Tough, and L. Lefrancois. 2005. Initial T cell frequency dictates memory CD8+ T cell lineage commitment. Nat. Immunol. 6:793–799. - PMC - PubMed

Publication types

MeSH terms

Substances